PUBLISHER: The Business Research Company | PRODUCT CODE: 2127588
PUBLISHER: The Business Research Company | PRODUCT CODE: 2127588
A ribonucleic acid (RNA) extraction machine is an automated laboratory device developed to isolate and purify RNA from biological samples. It utilizes specialized reagents and advanced extraction technologies to produce high-quality RNA suitable for molecular analysis. A ribonucleic acid (RNA) extraction machine enhances the accuracy, consistency, and efficiency of RNA preparation processes.
The primary product types of ribonucleic acid (RNA) extraction machines include manual ribonucleic acid extraction machines and automated ribonucleic acid extraction systems. Manual ribonucleic acid extraction machines refer to systems that require operator involvement to isolate RNA from biological samples through regulated extraction procedures. These machines utilize technologies such as column-based ribonucleic acid extraction and magnetic bead-based extraction and support workflows including pre-extraction workflow and extraction workflow. The key applications include sequencing, polymerase chain reaction testing, gene expression analysis, molecular diagnostics, genomic studies, and others, and they are used by end users including research laboratories, clinical diagnostics laboratories, biotechnology companies, pharmaceutical development companies, and genomic research institutes.
Tariffs are influencing the ribonucleic acid (RNA) extraction machine market by increasing the cost of imported precision instruments, automation components, and laboratory-grade consumables used in the manufacturing and deployment of extraction systems. This is increasing overall equipment prices and slowing adoption across clinical diagnostics, research laboratories, and biotechnology companies, particularly in import-dependent regions such as Asia-Pacific and Latin America. High reliance on global supply chains for robotics, sensors, and cartridge-based systems is further amplifying cost pressures in automated extraction machine segments. However, tariffs are also promoting localized manufacturing, regional supply chain diversification, and increased investment in domestic laboratory equipment production, improving long-term market resilience.
The ribonucleic acid (rna) extraction machine market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid (rna) extraction machine market statistics, including ribonucleic acid (rna) extraction machine industry global market size, regional shares, competitors with a ribonucleic acid (rna) extraction machine market share, detailed ribonucleic acid (rna) extraction machine market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (rna) extraction machine industry. This ribonucleic acid (rna) extraction machine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ribonucleic acid (RNA) extraction machine market size has grown rapidly in recent years. It will grow from $1.34 billion in 2025 to $1.5 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to rising adoption of molecular diagnostics in clinical laboratories, expansion of genomic and transcriptomic research activities, increasing prevalence of infectious and genetic diseases, growth in pharmaceutical and biotechnology r&d investments, standardization of automated laboratory workflows for nucleic acid extraction.
The ribonucleic acid (RNA) extraction machine market size is expected to see rapid growth in the next few years. It will grow to $2.27 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to increasing demand for precision medicine and personalized healthcare solutions, expansion of next generation sequencing based applications, rising automation in laboratory sample preparation workflows, growth of decentralized and point of care diagnostic systems, increasing investments in biotechnology infrastructure and genomic research ecosystems. Major trends in the forecast period include AI integrated automated rna extraction systems enabling high precision and reduced manual errors, fully automated high throughput extraction platforms supporting large scale genomic workflows, magnetic bead based extraction technologies improving yield and purity of nucleic acids, cartridge based closed system extraction machines enhancing contamination free processing, cloud connected laboratory extraction systems enabling remote monitoring and workflow optimization.
The rising prevalence of infectious diseases is expected to propel the growth of the ribonucleic acid (RNA) extraction machine market going forward. Infectious diseases are illnesses caused by the invasion and multiplication of harmful microorganisms, including viruses, bacteria, fungi, or parasites, within the human body. The increase in infectious diseases is driven by rapid urbanization, as densely populated urban environments facilitate the transmission of contagious illnesses through close human interaction. RNA extraction machines support infectious disease management by enabling automated RNA isolation, high-throughput sample processing, and accurate molecular diagnostic workflows. For instance, in May 2026, according to the UK Health Security Agency, a UK-based government agency, between 1 January and 25 May 2026, England reported 630 laboratory-confirmed measles cases, an increase of 88 cases compared with the previous report published on 11 May 2026. Therefore, the rising prevalence of infectious diseases is driving the growth of the ribonucleic acid (RNA) extraction machine market.
The expansion of personalized medicine is expected to propel the growth of the ribonucleic acid (RNA) extraction machine market going forward. Personalized medicine refers to a healthcare approach that customizes medical treatments based on an individual's genetic, molecular, and biomarker characteristics to enhance therapeutic outcomes and disease management. The growth of personalized medicine is fueled by advances in genomic sequencing technologies, which have made genetic testing faster, more accessible, and cost-effective for supporting targeted therapies and individualized treatment strategies. RNA extraction machines play a vital role in personalized medicine by isolating high-quality RNA from patient samples, enabling accurate gene expression analysis for biomarker discovery and informed treatment selection. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, compared with six approvals in 2022. Therefore, the expansion of personalized medicine is driving the growth of the ribonucleic acid (RNA) extraction machine market.
Major companies operating in the ribonucleic acid (RNA) extraction machine market are concentrating on developing advanced automated sample processing platforms to enhance nucleic acid purification efficiency, increase processing capacity, and minimize manual laboratory effort. Automated sample processing platforms are integrated systems designed to streamline the extraction and purification of RNA and DNA from biological samples with minimal human intervention, ensuring consistent and reliable outcomes. For instance, in January 2023, QIAGEN, a Netherlands-based provider of sample and assay technologies, launched the EZ2 Connect MDx platform for diagnostic laboratories. The automated platform enables the parallel purification of RNA and DNA from up to 24 samples in as little as 30 minutes using magnetic bead technology. It features prefilled reagent cartridges, onboard pipetting, heating capabilities, UV decontamination, and digital connectivity to improve workflow efficiency, operational safety, and laboratory automation for molecular diagnostic applications.
Major companies operating in the ribonucleic acid (RNA) extraction machine market report are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Revvity, QIAGEN N.V., Promega Corporation, Analytik Jena GmbH+Co. KG, Bioneer Corporation, Tiangen Biotech (Beijing) Co. Ltd., Hamilton Company, Tecan Group Ltd., Beckman Coulter, LGC Biosearch Technologies
North America was the dominating region in the ribonucleic acid (RNA) extraction machine market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) extraction machine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the ribonucleic acid (RNA) extraction machine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The ribonucleic acid (RNA) extraction machine market consists of sales of nucleic acid purification cartridges, robotic liquid handling extraction systems, automated sample preparation modules, extraction reagent packs, and high-throughput nucleic acid purification systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, healthcare laboratories, research institutes, and retailers) or directly to end customers. The value of goods in this market includes related software, maintenance, installation, calibration, and technical support services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ribonucleic Acid (RNA) Extraction Machine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses ribonucleic acid (rna) extraction machine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ribonucleic acid (rna) extraction machine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ribonucleic acid (rna) extraction machine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.